News for Magenta Therapeutics, Inc. (MGTA)

Dianthus aims for pharmaceutical success with DNTH-103, a promising drug targeting complement system disorders. Click here to read my most recent analysis.

LONDON, April 01, 2024 -- Autolus Therapeutics plc , a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announces the appointment of Mike...

Files Preliminary Proxy Statement to Solicit Shareholders to Oppose the Merger Intends to Vote AGAINST the Conflict-Plagued and Excessively Dilutive Transaction, Which Stands to Unduly Benefit...

Introduction to the Transaction On September 29, 2023, FMR LLC (Trades, Portfolio), a prominent investment firm, made a significant move in the biotechnology s

In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.

– Stephen Mahoney appointed President and Chief Executive Officer – – Potential best-in-class subcutaneous and intravenous thyroid eye disease programs targeting insulin-like growth factor 1...

DNTH | Complete Dianthus Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced the...

The combined company will operate as “Dianthus Therapeutics, Inc.” with its common stock traded on Nasdaq under trading symbol “DNTH” effective Tuesday,...

Increase in the prevalence of chronic diseases, advances in stem cell research, and growth in investment in regenerative medicine are prominent factors...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

NEW YORK, May 17, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the...

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

Read Analyzing bluebird bio (NASDAQ:BLUE) and Genocea Biosciences (NASDAQ:GNCA) at ETF Daily News

EQS-News: Heidelberg Pharma AG / Key word: Quarterly / Interim Statement Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2022 13.10.2022 / 07:06... | October 13, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to list on a major U.S. stock exchange.

Read Equities Research Analysts’ Downgrades for May 18th (APO, APPF, AZN, BYCBF, CARR, CCBG, CENX, CF, CLH, CRH) at ETF Daily News

Read Investment Analysts’ Upgrades for May 11th (ADDYY, AHT, ARCT, ARTNA, ARWR, ASHTY, AZEK, BNCDY, CELH, CLB) at ETF Daily News